NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: A possible role in ulcerative colitis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Itani, Shigehiro ^a   Watanabe, Toshio ^a,b   Nadatani, Yuji ^a   Sugimura, Naoki ^a   Shimada, Sunao ^a   Takeda, Shogo ^a   Otani, Koji ^a   Hosomi, Shuhei ^a   Nagami, Yasuaki ^a   Tanaka, Fumio ^a   Kamata, Noriko ^a   Yamagami, Hirokazu ^a   Tanigawa, Tetsuya ^a,b   Shiba, Masatsugu ^a   Tominaga, Kazunari ^a,b   Fujiwara, Yasuhiro ^a,b   Arakawa, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAMURAI International GI Research Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; CYTOKINE; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME; NLRP3 PROTEIN, HUMAN; OXAZOLONE;

ADULT; AGED; ANIMAL; CHEMICALLY INDUCED; COLITIS; DISEASE MODEL; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKOUT; GENETICS; HUMAN; IMMUNOLOGY; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; MOUSE; SEVERITY OF ILLNESS INDEX; ULCERATIVE COLITIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CASPASE 1; COLITIS; COLITIS, ULCERATIVE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HUMANS; INFLAMMASOMES; MACROPHAGES; MALE; MICE; MIDDLE AGED; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; OXAZOLONE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 85006152635     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep39075     Document Type: Article

References (39)

1. Galitovskiy, V. et al. Cytokine-induced alterations of alpha7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis. J Immunol 187, 2677-2687, doi: 10.4049/jimmunol.1002711 (2011).
2. Heller, F., Fuss, I. J., Nieuwenhuis, E. E., Blumberg, R. S. & Strober, W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17, 629-638 (2002).
3. Kojima, R., Kuroda, S., Ohkishi, T., Nakamaru, K. & Hatakeyama, S. Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis. J Pharmacol Sci 96, 307-313 (2004).
4. Martinon, F. & Tschopp, J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117, 561-574, doi: 10.1016/j.cell.2004.05.004 (2004).
5. Yu, H. B. & Finlay, B. B. The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe 4, 198-208, doi: 10.1016/j.chom.2008.08.007 (2008).
6. Petrilli, V., Dostert, C., Muruve, D. A. & Tschopp, J. The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 19, 615-622, doi: 10.1016/j.coi.2007.09.002 (2007).
7. Villani, A. C. et al. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet 41, 71-76, doi: 10.1038/ng.285 (2009).
8. Schoultz, I. et al. Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men. Am J Gastroenterol 104, 1180-1188, doi: 10.1038/ajg.2009.29 (2009).
9. Dupaul-Chicoine, J. et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32, 367-378, doi: 10.1016/j.immuni.2010.02.012 (2010).
10. Zaki, M. H. et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379-391, doi: 10.1016/j.immuni.2010.03.003 (2010).
11. Bauer, C. et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 59, 1192-1199, doi: 10.1136/gut.2009.197822 (2010).
12. Nishiyama, S. et al. Clinical usefulness of endocytoscopy in the remission stage of ulcerative colitis: a pilot study. J Gastroenterol 50, 1087-1093, doi: 10.1007/s00535-015-1059-y (2015).
13. Allen, A., Hutton, D. A. & Pearson, J. P. The MUC2 gene product: a human intestinal mucin. Int J Biochem Cell Biol 30, 797-801 (1998).
14. Higashimori, A. et al. Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy. Mucosal Immunol, doi: 10.1038/mi.2015.89 (2015).
15. Zaki, M. H., Lamkanfi, M. & Kanneganti, T. D. The Nlrp3 inflammasome: contributions to intestinal homeostasis. Trends Immunol 32, 171-179, doi: 10.1016/j.it.2011.02.002 (2011).
16. Hirota, S. A. et al. NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis 17, 1359-1372, doi: 10.1002/ibd.21478 (2011).
17. Zenewicz, L. A., Antov, A. & Flavell, R. A. CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med 15, 199-207, doi: 10.1016/j.molmed.2009.03.002 (2009).
18. Fujino, S. et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65-70 (2003).
19. Siegmund, B. et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol 281, R1264-1273 (2001).
20. Siegmund, B. Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammation. Biochem Pharmacol 64, 1-8 (2002).
21. Sivakumar, P. V. et al. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50, 812-820 (2002).
22. Takagi, H. et al. Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand J Gastroenterol 38, 837-844 (2003).
23. Shibuya, K. et al. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFNgamma in BALB/c but not C57BL/6 mice. J Immunol 160, 1708-1716 (1998).
24. Novick, D., Kim, S., Kaplanski, G. & Dinarello, C. A. Interleukin-18, more than a Th1 cytokine. Semin Immunol 25, 439-448, doi: 10.1016/j.smim.2013.10.014 (2013).
25. Gurung, P. et al. An NLRP3 inflammasome-triggered Th2-biased adaptive immune response promotes leishmaniasis. J Clin Invest 125, 1329-1338, doi: 10.1172/JCI79526 (2015).
26. Kroeger, K. M., Sullivan, B. M. & Locksley, R. M. IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alphadependent pathway. J Leukoc Biol 86, 769-778, doi: 10.1189/jlb.0708452 (2009).
27. Niebuhr, M., Baumert, K., Heratizadeh, A., Satzger, I. & Werfel, T. Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu. Allergy 69, 1058-1067, doi: 10.1111/all.12428 (2014).
28. Besnard, A. G. et al. NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant. Allergy 66, 1047-1057, doi: 10.1111/j.1398-9995.2011.02586.x (2011).
29. Gris, D. et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol 185, 974-981, doi: 10.4049/jimmunol.0904145 (2010).
30. Hu, C. et al. NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets. Proc Natl Acad Sci USA 112, 11318-11323, doi: 10.1073/pnas.1513509112 (2015).
31. Johansson, M. E. et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 105, 15064-15069, doi: 10.1073/pnas.0803124105 (2008).
32. Van der Sluis, M. et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131, 117-129, doi: 10.1053/j.gastro.2006.04.020 (2006).
33. Iwashita, J. et al. mRNA of MUC2 is stimulated by IL-4, IL-13 or TNF-alpha through a mitogen-activated protein kinase pathway in human colon cancer cells. Immunol Cell Biol 81, 275-282, doi: 10.1046/j.1440-1711.2003.t01-1-01163.x (2003).
34. Engler, D. B. et al. Helicobacter pylori-specific protection against inflammatory bowel disease requires the NLRP3 inflammasome and IL-18. Inflamm Bowel Dis 21, 854-861, doi: 10.1097/MIB.0000000000000318 (2015).
35. Prakash, R., Bharathi Raja, S., Devaraj, H. & Devaraj, S. N. Up-regulation of MUC2 and IL-1beta expression in human colonic epithelial cells by Shigella and its interaction with mucins. PLoS One 6, e27046, doi: 10.1371/journal.pone.0027046 (2011).
36. Enss, M. L. et al. Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm Res 49, 162-169, doi: 10.1007/s000110050576 (2000).
37. Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757, doi: 10.1016/j. cell.2011.04.022 (2011).
38. Elinav, E., Henao-Mejia, J. & Flavell, R. A. Integrative inflammasome activity in the regulation of intestinal mucosal immune responses. Mucosal Immunol 6, 4-13, doi: 10.1038/mi.2012.115 (2013).
39. Kennedy, R. J. et al. Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease. Br J Surg 87, 1346-1351, doi: 10.1046/j.1365-2168.2000.01615.x (2000).